188 related articles for article (PubMed ID: 2992753)
1. Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin-doxorubicin.
Pratt CB; Champion JE; Senzer N; Green AA; Rao B; Douglass E; Meyer WE; Crom DB
Cancer; 1985 Oct; 56(8):1930-3. PubMed ID: 2992753
[TBL] [Abstract][Full Text] [Related]
2. Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial.
Ferguson WS; Harris MB; Goorin AM; Gebhardt MC; Link MP; Shochat SJ; Siegal GP; Devidas M; Grier HE
J Pediatr Hematol Oncol; 2001; 23(6):340-8. PubMed ID: 11563767
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
4. Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults.
Patel SJ; Lynch JW; Johnson T; Carroll RR; Schumacher C; Spanier S; Scarborough M
Am J Clin Oncol; 2002 Oct; 25(5):489-95. PubMed ID: 12393991
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant treatment of osteosarcoma and malignant fibrous histiocytoma of the bones of the extremities: preliminary results in 76 cases treated preoperatively with a methotrexate and cisplatin combination].
Bacci G; Mercuri M; Pignatti G; Picci P; Guerra A; Albisinni U; Galletti S; Manfrini M; Orlandi M; Dallari D
Chir Organi Mov; 1985; 70(4):303-14. PubMed ID: 3009102
[No Abstract] [Full Text] [Related]
6. Metastatic osteosarcoma.
Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study.
Nooij MA; Whelan J; Bramwell VH; Taminiau AT; Cannon S; Hogendoorn PC; Pringle J; Uscinska BM; Weeden S; Kirkpatrick A; Glabbeke Mv; Craft AW;
Eur J Cancer; 2005 Jan; 41(2):225-30. PubMed ID: 15661546
[TBL] [Abstract][Full Text] [Related]
8. Multicentric synchronous osteosarcoma: a case report with autopsy findings.
Sasaki K; Yasui N; Fujikawa K
J Orthop Sci; 2000; 5(3):302-6. PubMed ID: 10982673
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study.
Bramwell VH; Steward WP; Nooij M; Whelan J; Craft AW; Grimer RJ; Taminau AH; Cannon SR; Malcolm AJ; Hogendoorn PC; Uscinska B; Kirkpatrick AL; Machin D; Van Glabbeke MM
J Clin Oncol; 1999 Oct; 17(10):3260-9. PubMed ID: 10506628
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H
J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444
[TBL] [Abstract][Full Text] [Related]
11. Failure of bleomycin to improve the therapeutic effects of a combination of cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced sarcomas.
Edmonson JH; Creagan ET; Kvols LK; Richardson RL; Rubin J; Green SJ
Med Pediatr Oncol; 1984; 12(4):264-6. PubMed ID: 6205246
[TBL] [Abstract][Full Text] [Related]
12. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
[TBL] [Abstract][Full Text] [Related]
14. Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin.
Fox E; Levin K; Zhu Y; Segers B; Balamuth N; Womer R; Bagatell R; Balis F
Oncologist; 2018 Jul; 23(7):762-e79. PubMed ID: 29445029
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment of metastatic and refractory osteosarcoma by ifosfamide, carboplatin and vindesine: case report].
Fujita H; Kiyokawa N; Takada K; Kyo K; Ishimoto K; Yabuta K; Mizuno T
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2167-70. PubMed ID: 1888188
[TBL] [Abstract][Full Text] [Related]
16. Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.
Meazza C; Cefalo G; Massimino M; Daolio P; Pastorino U; Scanagatta P; Morosi C; Podda M; Ferrari A; Terenziani M; Spreafico F; Casanova M; Parafioriti A; Collini P; Gandola L; Bastoni S; Biassoni V; Schiavello E; Chiaravalli S; Puma N; Bergamaschi L; Luksch R
Med Oncol; 2017 Nov; 34(12):191. PubMed ID: 29094224
[TBL] [Abstract][Full Text] [Related]
17. [Osteosarcoma: ADM+CDDP therapy].
Hosaka M; Watanuki M; Itoi E
Nihon Rinsho; 2015 Feb; 73 Suppl 2():653-6. PubMed ID: 25831842
[No Abstract] [Full Text] [Related]
18. Haematopoietic marrow hyperplasia simulating transarticular skip metastasis in osteosarcoma.
Pui MH; Tan MH; Kuan JH; Pho RW
Australas Radiol; 1995 Aug; 39(3):303-5. PubMed ID: 7487772
[No Abstract] [Full Text] [Related]
19. Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
Hong S; Shin SJ; Jung M; Jeong J; Lee YJ; Shin KH; Roh JK; Rha SY
Oncology; 2011; 80(1-2):107-17. PubMed ID: 21677455
[TBL] [Abstract][Full Text] [Related]
20. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
Bacci G; Mercuri M; Briccoli A; Ferrari S; Bertoni F; Donati D; Monti C; Zanoni A; Forni C; Manfrini M
Cancer; 1997 Jan; 79(2):245-54. PubMed ID: 9010097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
